Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 11, 2022

SELL
$181.58 - $368.0 $28.9 Million - $58.6 Million
-159,278 Closed
0 $0
Q1 2022

Apr 28, 2022

SELL
$303.87 - $423.8 $4.55 Million - $6.35 Million
-14,984 Reduced 8.6%
159,278 $55.7 Million
Q4 2021

Jan 31, 2022

BUY
$347.28 - $421.83 $15.4 Million - $18.8 Million
44,451 Added 34.24%
174,262 $66.3 Million
Q3 2021

Oct 15, 2021

SELL
$405.61 - $524.84 $8.03 Million - $10.4 Million
-19,800 Reduced 13.23%
129,811 $52.7 Million
Q2 2021

Jul 22, 2021

BUY
$372.84 - $481.5 $17.9 Million - $23.1 Million
47,911 Added 47.11%
149,611 $70.8 Million
Q1 2021

Apr 22, 2021

SELL
$361.28 - $504.76 $17.8 Million - $24.9 Million
-49,400 Reduced 32.69%
101,700 $39.1 Million
Q4 2020

Jan 14, 2021

BUY
$292.7 - $370.96 $44.2 Million - $56.1 Million
151,100 New
151,100 $55.9 Million
Q1 2020

Apr 28, 2020

SELL
$209.2 - $335.53 $29.5 Million - $47.3 Million
-140,870 Closed
0 $0
Q4 2019

Feb 05, 2020

BUY
$288.29 - $335.49 $5.05 Million - $5.88 Million
17,533 Added 14.22%
140,870 $46.7 Million
Q3 2019

Oct 25, 2019

BUY
$266.84 - $378.23 $6.06 Million - $8.6 Million
22,725 Added 22.59%
123,337 $37.5 Million
Q2 2019

Aug 01, 2019

SELL
$300.59 - $368.15 $180,353 - $220,890
-600 Reduced 0.59%
100,612 $37 Million
Q1 2019

Apr 24, 2019

BUY
$272.57 - $321.18 $3.43 Million - $4.05 Million
12,600 Added 14.22%
101,212 $31.4 Million
Q4 2018

Jan 31, 2019

BUY
$272.46 - $366.54 $2.28 Million - $3.06 Million
8,350 Added 10.4%
88,612 $26.6 Million
Q3 2018

Oct 30, 2018

SELL
$279.04 - $367.06 $4 Million - $5.27 Million
-14,350 Reduced 15.17%
80,262 $29.5 Million
Q2 2018

Jul 30, 2018

BUY
$228.17 - $292.07 $21.6 Million - $27.6 Million
94,612 New
94,612 $26.4 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.4B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Ardevora Asset Management LLP Portfolio

Follow Ardevora Asset Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ardevora Asset Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Ardevora Asset Management LLP with notifications on news.